Fubo Ji

535 total citations
11 papers, 355 citations indexed

About

Fubo Ji is a scholar working on Molecular Biology, Cancer Research and Cell Biology. According to data from OpenAlex, Fubo Ji has authored 11 papers receiving a total of 355 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Cancer Research and 3 papers in Cell Biology. Recurrent topics in Fubo Ji's work include Cancer-related molecular mechanisms research (4 papers), MicroRNA in disease regulation (3 papers) and Autophagy in Disease and Therapy (2 papers). Fubo Ji is often cited by papers focused on Cancer-related molecular mechanisms research (4 papers), MicroRNA in disease regulation (3 papers) and Autophagy in Disease and Therapy (2 papers). Fubo Ji collaborates with scholars based in China, Germany and United States. Fubo Ji's co-authors include Junfang Ji, Bin Zhao, Xin‐Hua Feng, Lei Chen, Li Li, Yang Zhao, Xinyan Ji, Huan Yan, Shuying Shen and Yingcheng Yang and has published in prestigious journals such as Nature Communications, Genes & Development and PLoS ONE.

In The Last Decade

Fubo Ji

9 papers receiving 353 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fubo Ji China 5 196 136 95 83 76 11 355
Sofia M.E. Weiler Germany 8 178 0.9× 113 0.8× 48 0.5× 52 0.6× 40 0.5× 11 263
Anja Hohmeyer Germany 3 234 1.2× 60 0.4× 79 0.8× 122 1.5× 91 1.2× 3 390
Carlotta Raschioni Italy 9 284 1.4× 150 1.1× 158 1.7× 201 2.4× 141 1.9× 11 566
Zhifa Cao China 7 191 1.0× 61 0.4× 103 1.1× 89 1.1× 76 1.0× 11 380
Zheyong Liang China 9 274 1.4× 107 0.8× 112 1.2× 99 1.2× 22 0.3× 17 411
Luai Zarour United States 6 128 0.7× 56 0.4× 85 0.9× 153 1.8× 72 0.9× 9 353
Stefan Thomann Germany 8 151 0.8× 76 0.6× 48 0.5× 52 0.6× 34 0.4× 13 245
Qianze Dong China 13 320 1.6× 63 0.5× 122 1.3× 83 1.0× 56 0.7× 17 418
Zhongtang Lu China 7 275 1.4× 99 0.7× 137 1.4× 98 1.2× 23 0.3× 8 370

Countries citing papers authored by Fubo Ji

Since Specialization
Citations

This map shows the geographic impact of Fubo Ji's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fubo Ji with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fubo Ji more than expected).

Fields of papers citing papers by Fubo Ji

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fubo Ji. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fubo Ji. The network helps show where Fubo Ji may publish in the future.

Co-authorship network of co-authors of Fubo Ji

This figure shows the co-authorship network connecting the top 25 collaborators of Fubo Ji. A scholar is included among the top collaborators of Fubo Ji based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fubo Ji. Fubo Ji is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Ji, Fubo, Xianglei He, Yongzhi Zhao, et al.. (2025). Liver-specific gene PGRMC1 blocks c-Myc-induced hepatocarcinogenesis through ER stress-independent PERK activation. Nature Communications. 16(1). 50–50. 4 indexed citations
4.
Ji, Fubo, Lei Zhao, Yongzhi Zhao, et al.. (2024). Oncogenic Roles of Laminin Subunit Gamma‐2 in Intrahepatic Cholangiocarcinoma via Promoting EGFR Translation. Advanced Science. 11(21). e2309010–e2309010. 4 indexed citations
5.
Ding, Ran, Yilin Chen, Fubo Ji, et al.. (2024). The HRD1-SEL1L ubiquitin ligase regulates stress granule homeostasis in couple with distinctive signaling branches of ER stress. iScience. 27(7). 110196–110196. 1 indexed citations
6.
Ji, Fubo, Yan Zhang, Peipei Huang, et al.. (2022). Blocking hepatocarcinogenesis by a cytochrome P450 family member with female-preferential expression. Gut. 71(11). 2313–2324. 31 indexed citations
7.
Zhao, Lei, Fubo Ji, Zhaogang Liu, et al.. (2020). MiR‐125b Loss Activated HIF1α/pAKT Loop, Leading to Transarterial Chemoembolization Resistance in Hepatocellular Carcinoma. Hepatology. 73(4). 1381–1398. 56 indexed citations
8.
Ji, Fubo, Yongzhi Zhao, Wei Jia, et al.. (2020). Loss of miR-192-5p initiates a hyperglycolysis and stemness positive feedback in hepatocellular carcinoma. Journal of Experimental & Clinical Cancer Research. 39(1). 268–268. 22 indexed citations
9.
Guo, Xiaocan, Yang Zhao, Huan Yan, et al.. (2017). Single tumor-initiating cells evade immune clearance by recruiting type II macrophages. Genes & Development. 31(3). 247–259. 220 indexed citations
10.
Sun, Yulin, Fubo Ji, Mia R. Kumar, et al.. (2017). Transcriptome integration analysis in hepatocellular carcinoma reveals discordant intronic miRNA-host gene pairs in expression. International Journal of Biological Sciences. 13(11). 1438–1449. 16 indexed citations
11.
Qing, Ying, et al.. (2009). O523 Angiogenesis, vasculogenesis, and vasculogenic mimicry in ovarian cancer. International Journal of Gynecology & Obstetrics. 107(S2). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026